Isoflurane



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Anaesthesia 30.0%
Oral Surgery 8.5%
Drug Use For Unknown Indication 7.7%
General Anaesthesia 7.7%
Induction Of Anaesthesia 7.7%
Asthma 6.9%
Anaesthetic Premedication 6.2%
Product Used For Unknown Indication 5.4%
General Anesthesia 3.8%
Maintenance Of Anaesthesia 3.1%
Preoperative Care 2.3%
Detoxification 1.5%
Gastrectomy 1.5%
Hip Arthroplasty 1.5%
Sedation 1.5%
Status Epilepticus 1.5%
Accidental Exposure 0.8%
Caesarean Section 0.8%
Craniotomy 0.8%
Induction And Maintenance Of Anaesthesia 0.8%
Haemodynamic Instability 6.9%
Hyperthermia Malignant 6.9%
Kounis Syndrome 6.9%
Muscle Rigidity 6.9%
Nausea 6.9%
Nuclear Magnetic Resonance Imaging Brain Abnormal 6.9%
Overdose 6.9%
Respiratory Distress 6.9%
Rhabdomyolysis 6.9%
Amniotic Fluid Volume Decreased 3.4%
Arteriospasm Coronary 3.4%
Bronchospasm 3.4%
Cardio-respiratory Arrest 3.4%
Condition Aggravated 3.4%
Death 3.4%
End-tidal Co2 Increased 3.4%
Epilepsy 3.4%
Heart Sounds Abnormal 3.4%
Hepatic Failure 3.4%
Hepatorenal Syndrome 3.4%
Secondary
Anaesthesia 24.2%
Drug Use For Unknown Indication 16.3%
General Anaesthesia 16.0%
Induction Of Anaesthesia 8.3%
Product Used For Unknown Indication 7.7%
Maintenance Of Anaesthesia 4.9%
Premedication 3.7%
Drug Exposure During Pregnancy 3.4%
Prophylaxis 2.7%
Musculoskeletal Pain 1.8%
Status Epilepticus 1.5%
Hypotension 1.5%
Anaesthesia Reversal 1.3%
Epidural Anaesthesia 1.3%
Neuralgia 1.1%
Neuromuscular Blockade 1.1%
Neuromuscular Blockade Reversal 0.9%
Hypertension 0.8%
Sedation 0.8%
Drug Detoxification 0.7%
Therapeutic Agent Toxicity 10.4%
Torsade De Pointes 10.4%
Ventricular Tachycardia 7.5%
Tachypnoea 6.7%
Myotonia 6.0%
Somatoform Disorder 6.0%
Sinus Tachycardia 5.2%
Tearfulness 4.5%
Unresponsive To Stimuli 4.5%
Urinoma 4.5%
Vomiting 4.5%
Conversion Disorder 3.7%
Respiratory Distress 3.7%
Shock 3.7%
Tachycardia 3.7%
Death 3.0%
Drug Exposure During Pregnancy 3.0%
Hypotension 3.0%
Incorrect Route Of Drug Administration 3.0%
Procedural Vomiting 3.0%
Concomitant
Product Used For Unknown Indication 30.0%
Anaesthesia 12.4%
Induction Of Anaesthesia 9.5%
Maintenance Of Anaesthesia 8.0%
General Anaesthesia 6.5%
Coronary Artery Bypass 5.5%
Drug Use For Unknown Indication 5.3%
Premedication 2.8%
Sedation 2.3%
Hypertension 2.3%
Catheterisation Cardiac 2.2%
Aortic Valve Replacement 1.8%
Hypotension 1.6%
Major Depression 1.6%
Neuralgia 1.5%
Pain 1.5%
Analgesic Therapy 1.4%
Myelitis Transverse 1.4%
Mitral Valve Replacement 1.3%
Nasopharyngitis 1.3%
Pain 12.4%
Vomiting 7.1%
Anhedonia 6.5%
Emotional Distress 6.5%
Renal Failure Acute 6.5%
Renal Failure 5.9%
Serotonin Syndrome 5.9%
Therapeutic Agent Toxicity 5.3%
Drug Withdrawal Syndrome 4.7%
Injury 4.7%
Fear 4.1%
Unevaluable Event 4.1%
Anxiety 3.5%
Neuromuscular Blockade 3.5%
Renal Impairment 3.5%
Shock Haemorrhagic 3.5%
Ventricular Fibrillation 3.5%
Multi-organ Failure 2.9%
Myoclonus 2.9%
Procedural Complication 2.9%
Interacting
General Anaesthesia 37.0%
Osteotomy 16.0%
Musculoskeletal Pain 8.8%
Neuralgia 6.8%
Pain 5.7%
Anaesthesia 5.0%
Varicose Vein Operation 5.0%
Drug Use For Unknown Indication 4.6%
Maintenance Of Anaesthesia 3.9%
Induction Of Anaesthesia 3.1%
Product Used For Unknown Indication 1.7%
Analgesia 1.1%
Type 2 Diabetes Mellitus 0.6%
Endotracheal Intubation 0.4%
Antiemetic Supportive Care 0.2%
Dementia Alzheimer's Type 0.2%
Sinus Tachycardia 60.0%
Myotonia 20.0%
Drug Interaction 8.0%
No Adverse Event 6.0%
Movement Disorder 2.0%
Myoclonus 2.0%
Torsade De Pointes 2.0%